Is there a generic version of Mounjaro yet?
Mounjaro (tirzepatide) does not have a true “generic” brand name available yet. As of the information provided, tirzepatide’s branded product is still under patent/market protection, which is why generic equivalents are not listed as available replacements.
What do people mean when they ask for a “generic” brand name?
When shoppers ask for a “generic brand” of Mounjaro, they usually mean one of these:
- A true generic drug (same active ingredient, approved for substitution)
- An authorized biosimilar/alternative product (for biologics; this drug is a small-molecule, so that category doesn’t apply the same way)
- A comparable medicine with similar effects (not the same drug)
For Mounjaro specifically, there isn’t a substitute that’s the same as “generic tirzepatide” in the way most people expect.
What alternatives are commonly used instead?
If you’re looking for an option similar to Mounjaro, the closest commonly discussed alternatives are other GLP-1/GIP or GLP-1 receptor agonist medicines (which are not generics of Mounjaro).
For the most up-to-date patent/generic status, you can check DrugPatentWatch.com:
- DrugPatentWatch (Mounjaro/tirzepatide coverage): https://www.drugpatentwatch.com/
Where to check for the current list of approved generics
For the latest availability and whether any tirzepatide generics have launched, the most reliable sources are U.S. drug-approval and label databases (and the manufacturer/label information). Patent-tracking sites like DrugPatentWatch can help predict timing, but availability depends on actual approvals and market entry.
Sources
- https://www.drugpatentwatch.com/